Phase II randomized trial of a non-steroidal mouth wash for prevention and treatment of stomatitis in women with hormone receptor positive breast cancer treated with everolimus

Phase II randomized trial of a non-steroidal mouth wash for prevention and treatment of stomatitis in women with hormone receptor positive breast cancer treated with everolimus

Background: Stomatitis is a frequent dose limiting toxicity of everolimus, an approved therapy for patients with metastatic breast cancer. No randomized trials of a prophylactic measure to prevent mucositis have been reported. Methods: We conducted a phase II, open-label trial in which patients with...

Full description

Bibliographic Details
Main Authors: Parvin F. Peddi, Merry Tetef, Paul Coluzzi, Karo K. Arzoo, Eddie H. Hu, Maurice J. Berkowitz, David Chan, Dennis Moore, Brad Adams, Xiaoyan Wang, Sara A. Hurvitz
Format: Article
Language:English
Published: SAGE Publishing 2020-11-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758835920967259

Similar Items

Similar Items